ALLISON RILEY: Open Payments
NPI 1427729664 · SENECA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$864 in 57 payments from 15 companies in 2025. Trend: 2023 $563 · 2024 $476 · 2025 $864
Food & beverage: $864
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. | 19 | $200 |
| ABBVIE INC. | 12 | $189 |
| Gilead Sciences, Inc. | 5 | $89 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $82 |
| Janssen Biotech, Inc. | 4 | $68 |
| Madrigal Pharmaceuticals | 2 | $38 |
| Ipsen Biopharmaceuticals, Inc | 2 | $36 |
| PFIZER INC. | 2 | $31 |
| GENZYME CORPORATION | 1 | $22 |
| Daiichi Sankyo Inc. | 1 | $22 |
Products named: IBSRELA, LINZESS, XIFAXAN, TREMFYA, RINVOQ, DUPIXENT, MAVYRET, REZDIFFRA.
Industry payments across SC — which companies pay providers there.
